Latest News and Press Releases

DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for...

Newly Appointed Board Chair, Philip Astley-Sparke, Brings Transatlantic Late-Stage Development, Regulatory and Commercial Expertise Strengthened Leadership and Expanded U.S. Presence Positions SynOx...

Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Carcinoid Tumor Market" report has been added to ResearchAndMarkets.com's offering. The global demand for advanced carcinoid tumor treatments is...

Wilmington, Delaware, March 04, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation,...

Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Oncology NGS Market: Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends - Forecast up to 2029" report has been...

Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "NUT Midline Carcinoma Treatment Market by Treatment, by Route of Administration, by End-User, and By Region" report has been added to ...

Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Oncology Based in-Vivo CRO - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

Mit der Einführung der "ICPO Academy for Theranostics" und dem Aufbau eines globalen Netzwerks von ICPO-Centern hat sich die Foundation als international führend in der Wissensvermittlung und der...

Launching the "ICPO Academy for Theranostics" and creating its global network of ICPO Centers, the foundation has become an international leader in sharing knowledge and shaping standards in its...

REDWOOD CITY, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...